Tracking replication-competent HIV reservoirs in infected individuals
- PMID: 23380652
- DOI: 10.1097/COH.0b013e32835d6e1c
Tracking replication-competent HIV reservoirs in infected individuals
Abstract
Purpose of review: Prolonged suppression of plasma viremia is now achievable in a majority of HIV-infected individuals receiving antiretroviral therapy (ART). However, ART alone cannot eradicate HIV in infected individuals. The purpose of this review is to discuss the importance of tracking levels of infected CD4(+) T cells carrying replication-competent HIV in basic and clinical research and how the use of this virologic marker could help determine the efficacy of ART and several novel therapeutic strategies that are being proposed for eliminating persistent viral reservoir in infected individuals receiving ART.
Recent findings: In recent years, there has been a growing interest within the HIV/AIDS scientific community to develop therapeutic strategies aimed at eliminating persistently infected CD4(+) T cells in order to achieve a cure for HIV in infected individuals receiving ART. These approaches include administration of HIV-activating agents, modification of the genetics of CD4(+) T cells, stem cell transplantation, and therapeutic vaccination. Such approaches would ultimately require careful and accurate assessments of the effect of therapeutic agents on HIV burden in infected individuals.
Summary: Given that the majority of infected CD4(+) T cells in vivo carry replication-defective HIV, longitudinal measurements of the frequency of cells carrying replication-competent HIV along with other quantitative virologic parameters, such as levels of plasma viremia and cell-associated viral nucleic acid, can provide critical insight into the dynamics of the persistent viral reservoirs. Information related to HIV pathogenesis and the feasibility of eradicating the virus in infected individuals receiving ART in combination with novel therapeutic agents can also be gained from these analyses.
Similar articles
-
HIV reservoirs: pathogenesis and obstacles to viral eradication and cure.AIDS. 2012 Jun 19;26(10):1261-8. doi: 10.1097/QAD.0b013e328353f3f1. AIDS. 2012. PMID: 22472858 Review.
-
Reservoirs for HIV-1: mechanisms for viral persistence in the presence of antiviral immune responses and antiretroviral therapy.Annu Rev Immunol. 2000;18:665-708. doi: 10.1146/annurev.immunol.18.1.665. Annu Rev Immunol. 2000. PMID: 10837072 Review.
-
Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection.Nature. 1997 May 8;387(6629):183-8. doi: 10.1038/387183a0. Nature. 1997. PMID: 9144289
-
Comparative analysis of measures of viral reservoirs in HIV-1 eradication studies.PLoS Pathog. 2013 Feb;9(2):e1003174. doi: 10.1371/journal.ppat.1003174. Epub 2013 Feb 14. PLoS Pathog. 2013. PMID: 23459007 Free PMC article.
-
New assays for monitoring residual HIV burden in effectively treated individuals.Curr Opin HIV AIDS. 2013 Mar;8(2):106-10. doi: 10.1097/COH.0b013e32835d811b. Curr Opin HIV AIDS. 2013. PMID: 23314907 Free PMC article. Review.
Cited by
-
HIV-1 Genetic Variation Resulting in the Development of New Quasispecies Continues to Be Encountered in the Peripheral Blood of Well-Suppressed Patients.PLoS One. 2016 May 19;11(5):e0155382. doi: 10.1371/journal.pone.0155382. eCollection 2016. PLoS One. 2016. PMID: 27195985 Free PMC article.
-
Inhibition of Heat Shock Protein 90 Prevents HIV Rebound.J Biol Chem. 2016 May 6;291(19):10332-46. doi: 10.1074/jbc.M116.717538. Epub 2016 Mar 8. J Biol Chem. 2016. PMID: 26957545 Free PMC article.
-
Rational development of radiopharmaceuticals for HIV-1.Nucl Med Biol. 2014 Apr;41(4):299-308. doi: 10.1016/j.nucmedbio.2014.01.005. Epub 2014 Jan 17. Nucl Med Biol. 2014. PMID: 24607432 Free PMC article. Review.
-
Persistent HIV-1 transcription in CD4+ T cells from ART-suppressed individuals can originate from biologically competent proviruses.J Virus Erad. 2021 Sep 15;7(3):100053. doi: 10.1016/j.jve.2021.100053. eCollection 2021 Sep. J Virus Erad. 2021. PMID: 34621530 Free PMC article.
-
HIV-infected cells are frequently clonally expanded after prolonged antiretroviral therapy: implications for HIV persistence.J Virus Erad. 2015 Oct 1;1(4):237-44. doi: 10.1016/S2055-6640(20)30930-4. J Virus Erad. 2015. PMID: 27482422 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials